Form 4 for NHC NATIONAL HEALTHCARE CORP
Accepted 2026-03-16 00:00:00 ET · period of report 2026-03-12 · accession 0001437749-26-008414 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-16 | 2026-03-12 | NHC | Flatt Stephen Fowler | CEO, Dir | M - OptEx | $53.94 | +1,853 | 65.5K | +3% | +$100.0K |
| D | 2026-03-16 | 2026-03-12 | NHC | Flatt Stephen Fowler | CEO, Dir | M - OptEx | $0.00 | -1,853 | 4,294 | -30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-12 | M | A | 1,853 | $53.94 | 65,505 | D | — | — | (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| 2 | Derivative | Option to Purchase Common Stock | 2026-03-12 | M | D | 1,853 | $0.00 | 4,294 | D | $53.94 · 2024-03-08 to 2028-03-08 | 6,147 Common Stock | (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |